文献速递烧伤创面修复

两例>90%TBSA全层烧伤应用NovoSorb与RECELL治疗的病例经验

Lessons Learned From Two Survivors of Greater Than 90% TBSA Full-Thickness Burn Injuries Using NovoSorb Biodegradable Temporizing Matrix™ and Autologous Skin Cell Suspension, RECELL™: A Case Series.
PubMed 文献 · J Burn Care Res · 2021-01-01

本文报告两例全层烧伤面积大于90% TBSA患者的治疗过程,采用分期、多模式方案:早期以NovoSorb可降解临时基质和同种异体皮覆盖切痂创面,结合RECELL自体细胞悬液与自体/异体皮移植,以实现复苏、限制液体丢失并最终完成皮肤覆盖。两例患者均存活。

要点

  • 大于90%TBSA全层烧伤中,早期用NovoSorb临时基质和同种异体皮覆盖切痂创面可限制液体丢失和全身炎症反应。
  • RECELL自体细胞悬液联合自体皮和异体皮应用是该分期方案中实现最终皮肤覆盖的组成部分。
  • 该病例系列显示两例大于90%TBSA全层烧伤患者经此多模式方案治疗后均存活。

核心结论

  • 对大于90%TBSA全层烧伤患者,采用NovoSorb可降解临时基质联合RECELL自体细胞悬液的分期多模式方案,两例患者均存活。

研究设计与样本

  • 病例系列,描述两例大于90%TBSA全层烧伤患者的治疗过程。

主要发现

  • 早期使用同种异体皮和NovoSorb可降解临时基质覆盖切痂创面,通过限制全身炎症反应综合征和液体丢失改善代谢控制。
  • 分期方案结合RECELL自体细胞悬液与自体皮和异体皮应用,最终实现皮肤覆盖。
  • 两例患者均经该方案治疗后存活。

临床怎么用

  • 对大面积全层烧伤,可考虑早期以同种异体皮和NovoSorb临时基质覆盖切痂创面以限制液体丢失和炎症反应。
  • 在分期方案中可将RECELL自体细胞悬液与自体皮和异体皮联合应用以促进最终皮肤覆盖。

局限性

  • 本文为病例系列,仅报告两例患者,未设对照,结论的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since autologous split-thickness skin grafts are scarce and lab skin growth requires a significant amount of time, there are limited available treatment approaches for patients with full-thickness burns greater than 90% TBSA. Additionally, to achieve the primary goal of skin coverage and resuscitation, there must exist a balance between fluid loss and metabolic derangement. Allografts and xenografts have traditionally been used early in the process to achieve these goals. Currently, novel approaches to treatment consider the additional use of synthetic dermal substitutes and autologous skin cell suspension to improve outcomes. This case series describes the treatment course of patients with greater than 90% TBSA full-thickness burn injuries using a staged, multifaceted approach of using NovoSorb Biodegradable Temporizing Matrix™ as the primary dermal substitute in conjunction with a RECELL™ Autologous Cell Suspensions Device applied with autograft and allograft to achieve improved resuscitation, limiting fluid loss, and finally skin coverage. Allograft and NovoSorb Biodegradable Temporizing Matrix™ were used early to cover excised burns, resulting in improved metabolic control by limiting the systemic inflammatory response syndrome and fluid loss. Both patients survived using this approach.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Malkoc A, Wong DT. Lessons Learned From Two Survivors of Greater Than 90% TBSA Full-Thickness Burn Injuries Using NovoSorb Biodegradable Temporizing Matrix™ and Autologous Skin Cell Suspension, RECELL™: A Case Series. J Burn Care Res. 2021. PMID: 33022032. doi:10.1093/jbcr/iraa176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。